Dr. Filemon Dela Cruz, a pediatric hematologist-oncologist at MSK, shared his poster on “Preclinical evaluation of PEG-[SN22]₄ (PEEL-224)...

Memorial Sloan Kettering Cancer Center· @MSKCancerCenter · X·2026-04-21 22:00· 2026-04-21评分60

正文 · 原文

Dr. Filemon Dela Cruz, a pediatric hematologist-oncologist at MSK, shared his poster on “Preclinical evaluation of PEG-[SN22]₄ (PEEL-224), a multivalent polymeric camptothecin prodrug, in pediatric solid tumor patient-derived xenograft models” during #AACR26.
@aacr

热度 8 · 7 赞 · 0 回复 · 1 转发

会议摘要

1157NCT05329103 NCT06709495 NCT06721689按代号 PEEL-224 对上

Preclinical evaluation of PEG-[SN22]4 (PEEL-224), a multivalent polymeric camptothecin prodrug, in pediatric solid tumor patient-derived xenograft models

Filemon S. Dela Cruz, Kristina C. Guillan, Samantha Brosius, Armaan H. Siddiquee, Glorife Ibanez Sanchez, Daoqi You, Kristen Victor, Paul Calder, Trent Fowler, Joshua D. Schiffman, Andrew L. Kung

读摘要原文 →

来源：Memorial Sloan Kettering Cancer Center · x.com